LTRN Lantern Pharma Inc.

Fundamentals / CIK 0001763950 / USD

Lantern Pharma Inc. reported $8.52M in total assets and a net loss of $13.78M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LTRN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$0$0$0-$19.43MFY 2019 Net Income: -$2.43M2019FY 2020 Net Income: -$5.91M2020FY 2021 Net Income: -$12.36M2021FY 2022 Net Income: -$14.26M2022FY 2023 Net Income: -$15.96M2023FY 2024 Net Income: -$20.78M2024FY 2025 Net Income: -$17.12M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $11.51M $16.13M $11.89M $8.60M $7.57M $2.24M --
Total Operating Expenses $17.98M $22.22M $17.88M $14.43M $12.59M $5.91M $2.43M
Operating Income -$17.98M -$22.22M -$17.88M -$14.43M -$12.59M -- --
EBITDA -$17.96M -$22.20M -$17.86M -$14.42M -$12.58M -- --
Interest Income $438K $742K $765K $204K $68K -- --
Net Income -$17.12M -$20.78M -$15.96M -$14.26M -$12.36M -$5.91M -$2.43M
Basic EPS -$1.57 -$1.93 -$1.47 -$1.31 -$1.13 -$1.37 -$1.23
Diluted EPS -$1.57 -$1.93 -$1.47 -$1.31 -$1.13 -$1.37 -$1.23
Basic Shares Outstanding 10.9M 10.8M 10.8M 10.9M 10.9M 4.3M 2.0M
Diluted Shares Outstanding 10.9M 10.8M 10.8M 10.9M 10.9M 4.3M 2.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $1.57M $1.79M $1.72M $2.74M $2.44M $3.07M $3.26M $4.27M
Total Operating Expenses $5.38M $3.51M $3.41M $4.20M $4.35M $4.65M $4.77M $5.90M
Operating Income -$5.38M -$3.51M -$3.41M -$4.20M -$4.35M -$4.65M -$4.77M -$5.90M
EBITDA -$5.37M -$3.50M -$3.40M -$4.20M -$4.35M -$4.65M -$4.77M -$5.89M
Interest Income $27K $30K $42K $72K $101K $115K $150K $161K
Net Income $697K -$7.07M -$3.33M -$4.07M -$4.18M -$4.33M -$4.54M -$5.88M
Basic EPS $0.05 -$0.57 -$0.30 -- -$0.39 -$0.40 -$0.42 --
Diluted EPS -$0.37 -$0.57 -$0.30 -- -$0.39 -$0.40 -$0.42 --
Basic Shares Outstanding 13.5M 12.4M 11.3M -- 10.8M 10.8M 10.8M --
Diluted Shares Outstanding 13.6M 12.4M 11.3M -- 10.8M 10.8M 10.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $4.42M $7.51M $21.94M $37.20M $51.52M $19.23M $1.23M
Short-Term Investments $5.70M $16.50M $19.36M $17.99M $19.20M -- --
Cash & Short-Term Investments $10.12M $24.01M $41.30M $55.20M $70.73M $19.23M $1.23M
Total Current Assets $10.80M $25.25M $43.34M $58.72M $72.72M $20.24M $1.23M
Property, Plant & Equipment, Net $32K $47K $52K $48K $30K $22K $8.8K
Other Non-Current Assets $37K $37K $26K $18K $18K -- --
Total Non-Current Assets $233K $324K $306K $114K $1.23M $123K $200K
Total Assets $11.04M $25.57M $43.65M $58.84M $73.95M $20.36M $1.43M
Accounts Payable -- -- -- -- -- $108K --
Total Current Liabilities $4.50M $4.33M $2.68M $2.80M $2.33M $552K $489K
Total Non-Current Liabilities $0 $53K $61K $0 $53K $108K $0
Total Liabilities $4.50M $4.38M $2.74M $2.80M $2.38M $661K $489K
Total Debt (incl. Leases) $79K $244K $234K $53K $205K -- --
Common Stock $1.1K $1.1K $1.1K $1.1K $1.1K $622 $198
Retained Earnings -$93.15M -$76.03M -$55.24M -$39.28M -$25.02M -$12.66M -$6.75M
Accumulated Other Comp. Income $25K $154K -$107K -$371K -$93K -- --
Total Stockholders' Equity $6.53M $21.19M $40.91M $56.04M $71.57M $19.70M $943K
Total Equity $6.53M $21.19M $40.91M $56.04M $71.57M $19.70M $943K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $7.62M $6.66M $4.92M $4.42M $8.39M $6.06M $6.38M $7.51M
Short-Term Investments $11K $701K $1.41M $5.70M $3.97M $9.84M $13.34M $16.50M
Cash & Short-Term Investments $7.63M $7.36M $6.32M $10.12M $12.36M $15.90M $19.72M $24.01M
Total Current Assets $8.41M $8.46M $7.06M $10.80M $13.46M $17.20M $20.82M $25.25M
Property, Plant & Equipment, Net $21K $24K $28K $32K $36K $40K $44K $47K
Other Non-Current Assets $26K $26K $26K $37K $37K $37K $37K $37K
Total Non-Current Assets $111K $143K $166K $233K $166K $220K $273K $324K
Total Assets $8.52M $8.60M $7.22M $11.04M $13.63M $17.42M $21.10M $25.57M
Total Current Liabilities $5.65M $4.32M $3.78M $4.50M $4.04M $4.88M $4.29M $4.33M
Total Non-Current Liabilities $1.46M $7.50M $0 $0 $0 $14K $33K $53K
Total Liabilities $7.11M $11.82M $3.78M $4.50M $4.04M $4.90M $4.32M $4.38M
Total Debt (incl. Leases) $47K $40K $59K $79K $94K $145K $59K $244K
Common Stock $1.5K $1.3K $1.1K $1.1K $1.1K $1.1K $1.1K $1.1K
Retained Earnings -$102.8M -$103.5M -$96.47M -$93.15M -$89.07M -$84.89M -$80.56M -$76.03M
Accumulated Other Comp. Income -$46K -$40K -$36K $25K $40K $48K $132K $154K
Total Stockholders' Equity $1.41M -$3.22M $3.45M $6.53M $9.59M $12.52M $16.78M $21.19M
Total Equity $1.41M -$3.22M $3.45M $6.53M $9.59M $12.52M $16.78M $21.19M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$17.12M -$20.78M -$15.96M -$14.26M -$12.36M -$5.91M $2.43M
Depreciation & Amortization $17K $17K $15K $10K $6.8K $3.4K $1.6K
Stock-Based Compensation $651K $652K $1.02M $1.19M $962K -- --
Change in Payables -- -- -- -- -- -$169K --
Operating Cash Flow -$15.68M -$17.81M -$14.35M -$12.77M -$10.59M -$5.65M -$2.13M
Capital Expenditure -$1.7K -$13K -$19K -$28K -$15K -- --
Free Cash Flow -$15.68M -$17.83M -$14.37M -$12.80M -$10.61M -- --
Purchases of Investments -$14.72M -$17.28M -$8.20M -$3.91M -$19.58M -- --
Investing Cash Flow $11.06M $3.37M -$930K $179K -$19.53M -$16K -$5.7K
Common Stock Issued $1.62M -- -- -- $69.00M -- --
Share Repurchases -- -- -$500K -$2.48M -$940K -- --
Financing Cash Flow $1.50M $67K -$500K -$2.18M $63.42M $23.66M $2.92M
Net Change in Cash -$3.09M -$14.43M -$15.81M -$14.78M $33.30M $18.00M $787K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $697K -$7.07M -$3.33M -$4.07M -$4.18M -$4.33M -$4.54M -$5.88M
Depreciation & Amortization $3.5K $3.8K $3.9K $4.1K $4.1K $4.5K $4.6K $4.6K
Stock-Based Compensation -- -- -- $199K $144K $161K $148K $205K
Operating Cash Flow -$3.34M -$2.94M -$3.77M -$2.79M -$4.57M -$3.94M -$4.38M -$3.97M
Capital Expenditure -- -- -- -$1 -$555 $0 -$1.2K -$3.1K
Free Cash Flow -- -- -- -$2.79M -$4.57M -$3.94M -$4.38M -$3.97M
Purchases of Investments -- -- -- -$4.20M -$2.08M -$3.46M -$4.98M $201K
Investing Cash Flow $672K $692K $4.25M -$1.70M $5.93M $3.59M $3.24M $3.45M
Common Stock Issued $31K -- -- -- $31K -- -- --
Financing Cash Flow -- -- -- -- -- -- -- $0
Net Change in Cash $956K $1.74M $495K -$3.97M $2.33M -$316K -$1.13M -$592K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -262.0% -98.1% -39.0% -25.4% -17.3% -30.0% -257.4%
Return on Assets (ROA) -155.1% -81.3% -36.6% -24.2% -16.7% -29.0% -169.5%
Current Ratio 2.40x 5.83x 16.18x 20.99x 31.26x 36.64x 2.52x
Quick Ratio 2.25x 5.54x 15.42x 19.72x 30.40x 34.81x 2.52x
Debt to Equity 0.01x 0.01x 0.01x 0.00x 0.00x -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -977.1% -- -461.8% -262.0% -197.4% -153.7% -118.5% -98.1%
Return on Assets (ROA) -161.6% -216.8% -220.3% -155.1% -138.8% -110.5% -94.2% -81.3%
Current Ratio 1.49x 1.96x 1.87x 2.40x 3.33x 3.52x 4.86x 5.83x
Quick Ratio 1.35x 1.70x 1.67x 2.25x 3.06x 3.26x 4.60x 5.54x
Debt to Equity 0.03x -- 0.02x 0.01x 0.01x 0.01x 0.00x 0.01x
Source: SEC EDGAR CompanyFacts (CIK 0001763950) · from March 31, 2019 Data through September 30, 2026 · synced Nov 21, 2026, 05:08 UTC · Open in terminal